Kinases are attractive drug targets because they regulate numerous biological pathways. Small molecule drugs that block immune pathway kinases modulate inflammatory responses and could be effective antiviral and cancer therapies. To determine drug-kinase kinetics during screening and hit-to-lead, researchers need proven assays that are easy to develop and highly robust.
